Orphazyme A/S ADR
(ORPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | AZN | AMGN | GILD | BMY |
| Company | Orphazyme A/S ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.9060 | 205.89 | 363.65 | 150.66 | N/A |
| High | 0.9571 | 205.89 | 363.65 | 150.66 | N/A |
| Low | 0.8457 | 205.89 | 363.65 | 150.66 | N/A |
| Latest | 0.8700 | 205.47 | 365.17 | 152.79 | 60.34 |
| Change | -0.0200 | +0.95 | +1.49 | +0.98 | +0.48 |
| % Change | -2.25% | +0.46% | +0.41% | +0.65% | +0.80% |
| Volume | 941,400 | 27,908 | 4,660 | 8,431 | 11,177 |
| 20-Day Average Volume | 1,980,090 | 4,393,371 | 3,092,618 | 8,586,666 | 13,137,565 |
| Previous Close | 0.8900 | 204.52 | 366.20 | 151.81 | 59.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 189.64 | 353.17 | 141.83 | 57.01 |
| 20-Day Raw Stochastic | 41.76% | 100.00% | 66.14% | 81.16% | 77.03% |
| 20-Day Relative Strength | 36.52 | 65.72 | 58.94 | 65.61 | 64.73 |
| Weighted Alpha | -87.89 | +49.46 | +30.91 | +53.59 | +22.52 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 64% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | +6.66% since 02/06/26 | -5.38% since 02/06/26 | -1.21% since 02/06/26 | -3.05% since 02/06/26 |
| Low | 0.8275 on 03/29/22 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 0.9600 on 03/29/22 | 205.89 on 02/13/26 | 384.62 on 02/09/26 | 157.29 on 02/11/26 | 61.63 on 02/09/26 |
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | +8.93% since 01/13/26 | +12.13% since 01/13/26 | +23.74% since 01/13/26 | +7.47% since 01/13/26 |
| Low | 0.5101 on 03/14/22 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 53.54 on 01/21/26 |
| High | 1.3720 on 03/10/22 | 205.89 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | +16.18% since 11/13/25 | +8.23% since 11/13/25 | +20.34% since 11/13/25 | +23.58% since 11/13/25 |
| Low | 0.5101 on 03/14/22 | 176.56 on 11/14/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 2.7500 on 01/03/22 | 205.89 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | +32.08% since 08/13/25 | +25.69% since 08/13/25 | +25.40% since 08/13/25 | +25.59% since 08/13/25 |
| Low | 0.5101 on 03/14/22 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 5.4900 on 10/13/21 | 205.89 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 317,191,712 | 197,191,760 | 188,347,648 | 121,860,176 |
| Shares Outstanding, K | 35,312 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -97,010,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 1.68 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/05/22 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.28 | 16.78 | 19.12 | 9.74 |